USD10
IMRX delen
Info over ImmuneeringImmuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
USD10
IMRX delen
Info over ImmuneeringImmuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
Statistieken
HANDELSVENSTER
Gesloten
OPENT OM
20 mrt at 13:30 GMT+0
MARKTKAPITALISATIE
US$ 319,35 mln.
OPENINGSPRIJS
Onvoldoende gegevens
LAAG (1J)
US$ 1,10
HOOG (1J)
US$ 10,08
LAAG (24u)
US$ 4,67
HOOG (24H)
US$ 4,94
VOLUME (24 uur)
US$ 628,82K
13,72%
Prijsgeschiedenis
Time | Price | Change |
|---|---|---|
Vandaag | Onvoldoende gegevens | Onvoldoende gegevens |
1 dag | US$ 4,78 | |
1 week | US$ 5,45 | |
1 maand | US$ 5,25 | |
1 jaar | US$ 1,80 |